Indian stocks: Visit www.stage2stocks.com →

Alpha Cognition Inc.

Stage 2 · Advancing · week 16

As of Oct 22, 2026, Alpha Cognition is in Stage 2, the uptrend phase, now in week 16 (since Jul 1, 2026). It closed at $8.31, 14.8% below its 52-week high and above its 200-day average, which is rising.

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. More about the company

$8.31
-3.15% today
$181M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is ACOG early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2024-11-12 → 2026-10-22
S? 42w
S3 10w
S4 22w
S1 11w
S2 16w
2024-11-122026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S3 10w → S4 22w → S1 11w → S2 16w current
Total tracked: 101 weeks across 5 stage runs.

ACOG among Biotechnology135th of 591 by relative strength

All 591 →
Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#StockStageRS1M
1GTBPStage 2 · wk 799−22.3%
2IOVAStage 2 · wk 1899+38.8%
3SLSStage 3 · wk 499−1.5%
4MRNAStage 2 · wk 1799+11.3%
5TWSTStage 2 · wk 3999−14.5%
6KODStage 2 · wk 499+172.1%
7ERASStage 3 · wk 599+0.7%
8CLYMStage 3 · wk 399−15.8%
…135ACOGStage 2 · wk 1671−5.4%
vs 52W High
-14.8%
$4.50 lo$9.75 hi
14.8% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 16
1w13w26w
Week 16, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
17.5%
200 DMA: $7.07 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.62x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-5.4%
3M
+5.2%
6M
+21.3%
YTD
+27.8%
1Y
+21.3%
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-22S2
Wk 16 · Vol 1.62x
2026-10-21S2
Wk 16 · Vol 0.66x
2026-10-20S2
Wk 16 · Vol 0.75x
2026-10-19S2
Wk 16 · Vol 0.63x
2026-10-16S2
Wk 16 · Vol 0.55x
2026-10-15S2
Wk 15 · Vol 1.79x
2026-10-14S2
Wk 15 · Vol 0.59x
2026-10-13S2
Wk 15 · Vol 1.02x
2026-10-12S2
Wk 15 · Vol 0.38x
2026-10-09S2
Wk 15 · Vol 0.16x
2026-10-08S2
Wk 14 · Vol 0.74x
2026-10-07S2
Wk 14 · Vol 0.31x
Moving averages & range
50 DMA
$8.95
200 DMA
$7.07
52W High
$9.75
52W Low
$4.50
5D Low
$8.19
Resistance levels (recent highs)
20d High
$9.15
60d High
$9.75
120d High
$9.75
250d High
$9.75
Next resistance
+10.1%
to 20d High
ROE
-49.5%
Profit margin -137.7%
Dividend Yield
0.00%
P/B 3.4

Alpha Cognition: quick answers

What stage is Alpha Cognition in?

As of Oct 22, 2026, Alpha Cognition (ACOG) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 1, 2026 and is in week 16. What the four stages mean

Is Alpha Cognition in an uptrend?

Yes. Alpha Cognition is in a Stage 2 uptrend. It trades 17.5% above its 200-day average, which is rising.

How far is Alpha Cognition from its 52-week high?

Alpha Cognition closed at $8.31 on Oct 22, 2026, 14.8% below its 52-week high of $9.75. Its 52-week low is $4.50.

How has Alpha Cognition performed over the past year?

As of Oct 22, 2026, Alpha Cognition is up 21.3% over the past year and up 27.8% so far in 2026.

Which sector and industry is Alpha Cognition in?

Alpha Cognition is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.